Dendritic cells are one of the most important cells of the immune system, having the unique ability to stimulate naive T cells. Additionally, under specific conditions, dendritic cells can give rise to T regulatory cells and dampen immune responses.
The current patent teaches ways of generating dendritic cells from embryonic stem cells by culturing embryoid bodies with IL-3 and/or GM-CSF.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.